Genome editing revolutionize the creation of genetically modified pigs for modeling human diseases

Human Genetics

Volumn 135, Issue 9, 2016, Pages 1093-1105

  Yao, Jing ^a   Huang, Jiaojiao ^a   Zhao, Jianguo ^a,b  

^a INSTITUTE OF ZOOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CRISPR ASSOCIATED PROTEIN; TRANSCRIPTION ACTIVATOR LIKE EFFECTOR NUCLEASE; ZINC FINGER NUCLEASE;

CARDIOVASCULAR DISEASE; CELL NUCLEUS TRANSPLANTATION; CYSTIC FIBROSIS; DEGENERATIVE DISEASE; DISEASE MODEL; DNA END JOINING REPAIR; EYE DISEASE; GENE TARGETING; GENE TRANSFER; GENETIC ENGINEERING AND GENE TECHNOLOGY; GENOME EDITING; HOMOLOGOUS RECOMBINATION; IMMUNE DEFICIENCY; MEDICAL RESEARCH; METABOLIC DISORDER; MICROINJECTION; NONHUMAN; PORCINE MODEL; PRIORITY JOURNAL; REVIEW; TRANSGENIC ANIMAL; XENOTRANSPLANTATION; ANIMAL; GENE EDITING; GENETICS; HUMAN; PIG;

ANIMALS; DISEASE MODELS, ANIMAL; GENE EDITING; HUMANS; SWINE;

EID: 84978712593     PISSN: 03406717     EISSN: 14321203     Source Type: Journal    
DOI: 10.1007/s00439-016-1710-6     Document Type: Review

References (160)

1. (2012) Breakthrough of the year. The runners-up. Science 338: 1525-1532
2. Al-Mashhadi RH, Sorensen CB, Kragh PM et al (2013) Familial hypercholesterolemia and atherosclerosis in cloned minipigs created by DNA transposition of a human PCSK9 gain-of-function mutant. Sci Transl Med 5:166ra161
3. American Diabetes Association (2013) Diagnosis and classification of diabetes mellitus. Diabetes Care 36(Suppl 1):S67–S74
4. Auer TO, Duroure K, De Cian A, Concordet JP, Del Bene F (2014) Highly efficient CRISPR/Cas9-mediated knock-in in zebrafish by homology-independent DNA repair. Genome Res 24:142–153
5. Baguisi A, Behboodi E, Melican DT et al (1999) Production of goats by somatic cell nuclear transfer. Nat Biotechnol 17:456–461
6. Bao L, Chen H, Jong U et al (2014) Generation of GGTA1 biallelic knockout pigs via zinc-finger nucleases and somatic cell nuclear transfer. Sci China Life Sci 57:263–268
7. Barrangou R, Marraffini LA (2014) CRISPR-Cas systems: prokaryotes upgrade to adaptive immunity. Mol Cell 54:234–244
8. Barrangou R, Fremaux C, Deveau H et al (2007) CRISPR provides acquired resistance against viruses in prokaryotes. Science 315:1709–1712
9. Basnet NB, Ide K, Tahara H, Tanaka Y, Ohdan H (2010) Deficiency of N-glycolylneuraminic acid and Galalpha1-3Galbeta1-4GlcNAc epitopes in xenogeneic cells attenuates cytotoxicity of human natural antibodies. Xenotransplantation 17:440–448
10. Bedell VM, Wang Y, Campbell JM et al (2012) In vivo genome editing using a high-efficiency TALEN system. Nature 491:114–118
11. Beraldi R, Chan CH, Rogers CS et al (2015) A novel porcine model of ataxia telangiectasia reproduces neurological features and motor deficits of human disease. Hum Mol Genet 24:6473–6484
12. Bibikova M, Carroll D, Segal DJ, Trautman JK, Smith J, Kim YG, Chandrasegaran S (2001) Stimulation of homologous recombination through targeted cleavage by chimeric nucleases. Mol Cell Biol 21:289–297
13. Bibikova M, Golic M, Golic KG, Carroll D (2002) Targeted chromosomal cleavage and mutagenesis in Drosophila using zinc-finger nucleases. Genetics 161:1169–1175
14. Bibikova M, Beumer K, Trautman JK, Carroll D (2003) Enhancing gene targeting with designed zinc finger nucleases. Science 300:764
15. Boch J, Scholze H, Schornack S et al (2009) Breaking the code of DNA binding specificity of TAL-type III effectors. Science 326:1509–1512
16. Bolotin A, Quinquis B, Sorokin A, Ehrlich SD (2005) Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology 151:2551–2561
17. Brouns SJ, Jore MM, Lundgren M et al (2008) Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 321:960–964
18. Brown AJ, Fisher DA, Kouranova E et al (2013) Whole-rat conditional gene knockout via genome editing. Nat Methods 10:638–640
19. Cabot RA, Kuhholzer B, Chan AW et al (2001) Transgenic pigs produced using in vitro matured oocytes infected with a retroviral vector. Anim Biotechnol 12:205–214
20. Carlson DF, Fahrenkrug SC, Hackett PB (2012a) Targeting DNA With Fingers and TALENs. Mol Ther Nucleic Acids 1:e3
21. Carlson DF, Tan W, Lillico SG et al (2012b) Efficient TALEN-mediated gene knockout in livestock. Proc Natl Acad Sci USA 109:17382–17387
22. Chang K, Qian J, Jiang M et al (2002) Effective generation of transgenic pigs and mice by linker based sperm-mediated gene transfer. BMC Biotechnol 2:5
23. Chang N, Sun C, Gao L et al (2013) Genome editing with RNA-guided Cas9 nuclease in zebrafish embryos. Cell Res 23:465–472
24. Chen G, Qian H, Starzl T et al (2005) Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat Med 11:1295–1298
25. Chen Y, Zheng Y, Kang Y et al (2015) Functional disruption of the dystrophin gene in rhesus monkey using CRISPR/Cas9. Hum Mol Genet 24:3764–3774
26. Christian M, Cermak T, Doyle EL et al (2010) Targeting DNA double-strand breaks with TAL effector nucleases. Genetics 186:757–761
27. Cibelli JB, Stice SL, Golueke PJ et al (1998) Cloned transgenic calves produced from nonquiescent fetal fibroblasts. Science 280:1256–1258
28. Clark AJ, Bessos H, Bishop JO et al (1989) Expression of human anti-hemophilic factor IX in the milk of transgenic sheep. Bio/Technology 7:487–492
29. Cong L, Ran FA, Cox D et al (2013) Multiplex genome engineering using CRISPR/Cas systems. Science 339:819–823
30. Cooper DK, Ekser B, Ramsoondar J, Phelps C, Ayares D (2016) The role of genetically engineered pigs in xenotransplantation research. J Pathol 238:288–299
31. Cornu TI, Thibodeau-Beganny S, Guhl E, Alwin S, Eichtinger M, Joung JK, Cathomen T (2008) DNA-binding specificity is a major determinant of the activity and toxicity of zinc-finger nucleases. Mol Ther 16:352–358
32. Dai Y, Vaught TD, Boone J et al (2002) Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs. Nat Biotechnol 20:251–255
33. Davis BT, Wang XJ, Rohret JA et al (2014) Targeted disruption of LDLR causes hypercholesterolemia and atherosclerosis in Yucatan miniature pigs. PLoS One 9:e93457
34. Edwards AO, Miedziak A, Vrabec T, Verhoeven J, Acott TS, Weleber RG, Donoso LA (1999) Autosomal dominant Stargardt-like macular dystrophy: I. Clinical characterization, longitudinal follow-up, and evidence for a common ancestry in families linked to chromosome 6q14. Am J Ophthalmol 127:426–435
35. Estrada JL, Martens G, Li P et al (2015) Evaluation of human and non-human primate antibody binding to pig cells lacking GGTA1/CMAH/beta4GalNT2 genes. Xenotransplantation 22:194–202
36. Gao F, Shen XZ, Jiang F, Wu Y, Han C (2016) DNA-guided genome editing using the Natronobacterium gregoryi Argonaute. Nat Biotechnol 34:768–773
37. Garrels W, Mates L, Holler S et al (2011) Germline transgenic pigs by Sleeping Beauty transposition in porcine zygotes and targeted integration in the pig genome. PLoS One 6:e23573
38. Geurts AM, Cost GJ, Freyvert Y et al (2009) Knockout rats via embryo microinjection of zinc-finger nucleases. Science 325:433
39. Gordon K, Lee E, Vitale JA, Smith AE, Westphal H, Hennighausen L (1992) Production of human tissue plasminogen activator in transgenic mouse milk. 1987. Biotechnology 24:425–428
40. Griffin MA, Restrepo MS, Abu-El-Haija M et al (2014) A novel gene delivery method transduces porcine pancreatic duct epithelial cells. Gene Ther 21:123–130
41. Guilbault C, Saeed Z, Downey GP, Radzioch D (2007) Cystic fibrosis mouse models. Am J Respir Cell Mol Biol 36:1–7
42. Guo JJ, Stoltz DA, Zhu V, Volk KA, Segar JL, McCray PB Jr, Roghair RD (2014) Genotype-specific alterations in vascular smooth muscle cell function in cystic fibrosis piglets. J Cyst Fibros 13:251–259
43. Hai T, Teng F, Guo R, Li W, Zhou Q (2014) One-step generation of knockout pigs by zygote injection of CRISPR/Cas system. Cell Res 24:372–375
44. Hamel CP (2007) Cone rod dystrophies. Orphanet J Rare Dis 2:7
45. Hammer RE, Pursel VG, Rexroad CE Jr et al (1985) Production of transgenic rabbits, sheep and pigs by microinjection. Nature 315:680–683
46. Hao YH, Yong HY, Murphy CN et al (2006) Production of endothelial nitric oxide synthase (eNOS) over-expressing piglets. Transgenic Res 15:739–750
47. Haurwitz RE, Jinek M, Wiedenheft B, Zhou K, Doudna JA (2010) Sequence- and structure-specific RNA processing by a CRISPR endonuclease. Science 329:1355–1358
48. Hauschild J, Petersen B, Santiago Y et al (2011) Efficient generation of a biallelic knockout in pigs using zinc-finger nucleases. Proc Natl Acad Sci USA 108:12013–12017
49. Hickey RD, Lillegard JB, Fisher JE et al (2011) Efficient production of Fah-null heterozygote pigs by chimeric adeno-associated virus-mediated gene knockout and somatic cell nuclear transfer. Hepatology 54:1351–1359
50. Hickey RD, Mao SA, Glorioso J et al (2014) Fumarylacetoacetate hydrolase deficient pigs are a novel large animal model of metabolic liver disease. Stem Cell Res 13:144–153
51. Hockemeyer D, Wang H, Kiani S et al (2011) Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol 29:731–734
52. Hofmann A, Kessler B, Ewerling S et al (2003) Efficient transgenesis in farm animals by lentiviral vectors. EMBO Rep 4:1054–1060
53. Holm IE, Alstrup AK, Luo Y (2016) Genetically modified pig models for neurodegenerative disorders. J Pathol 238:267–287
54. Huang J, Guo X, Fan N et al (2014) RAG1/2 knockout pigs with severe combined immunodeficiency. J Immunol 193:1496–1503
55. Hwang WY, Fu Y, Reyon D et al (2013) Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol 31:227–229
56. Ishino Y, Shinagawa H, Makino K, Amemura M, Nakata A (1987) Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. J Bacteriol 169:5429–5433
57. Jansen R, Embden JD, Gaastra W, Schouls LM (2002) Identification of genes that are associated with DNA repeats in prokaryotes. Mol Microbiol 43:1565–1575
58. Jao LE, Wente SR, Chen W (2013) Efficient multiplex biallelic zebrafish genome editing using a CRISPR nuclease system. Proc Natl Acad Sci USA 110:13904–13909
59. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337:816–821
60. Kang JT, Kwon DK, Park AR et al (2016) Production of alpha1, 3-galactosyltransferase targeted pigs using transcription activator-like effector nuclease-mediated genome editing technology. J Vet Sci 17:89–96
61. Kapourchali FR, Surendiran G, Chen L, Uitz E, Bahadori B, Moghadasian MH (2014) Animal models of atherosclerosis. World J Clin Cases 2:126–132
62. Kim YG, Cha J, Chandrasegaran S (1996) Hybrid restriction enzymes: zinc finger fusions to FokI cleavage domain. Proc Natl Acad Sci USA 93:1156–1160
63. Kling J (2009) First US approval for a transgenic animal drug. Nat Biotechnol 27:302–304
64. Kling J (2011) Fresh from the biologic pipeline—2010. Nat Biotechnol 29:197–200
65. Klymiuk N, Mundhenk L, Kraehe K et al (2012) Sequential targeting of CFTR by BAC vectors generates a novel pig model of cystic fibrosis. J Mol Med (Berl) 90:597–608
66. Kolber-Simonds D, Lai L, Watt SR et al (2004) Production of alpha-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations. Proc Natl Acad Sci USA 101:7335–7340
67. Kostic C, Lillico SG, Crippa SV et al (2013) Rapid cohort generation and analysis of disease spectrum of large animal model of cone dystrophy. PLoS One 8:e71363
68. Kraft TW, Allen D, Petters RM, Hao Y, Peng YW, Wong F (2005) Altered light responses of single rod photoreceptors in transgenic pigs expressing P347L or P347S rhodopsin. Mol Vis 11:1246–1256
69. Kurome M, Ueda H, Tomii R, Naruse K, Nagashima H (2006) Production of transgenic-clone pigs by the combination of ICSI-mediated gene transfer with somatic cell nuclear transfer. Transgenic Res 15:229–240
70. Kuwaki K, Tseng YL, Dor FJ et al (2005) Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med 11:29–31
71. Lai L, Kolber-Simonds D, Park KW et al (2002) Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 295:1089–1092
72. Lavitrano M, Forni M, Varzi V et al (1997) Sperm-mediated gene transfer: production of pigs transgenic for a human regulator of complement activation. Transpl Proc 29:3508–3509
73. Lee HG, Lee HC, Kim SW et al (2009) Production of recombinant human von Willebrand factor in the milk of transgenic pigs. J Reprod Dev 55:484–490
74. Lee K, Kwon DN, Ezashi T et al (2014a) Engraftment of human iPS cells and allogeneic porcine cells into pigs with inactivated RAG2 and accompanying severe combined immunodeficiency. Proc Natl Acad Sci USA 111:7260–7265
75. Lee MH, Lin YS, Tu CF, Yen CH (2014b) Recombinant human factor IX produced from transgenic porcine milk. Biomed Res Int 2014:315375
76. Li G, Jiang P, Li Y et al (2009) Inhibition of porcine reproductive and respiratory syndrome virus replication by adenovirus-mediated RNA interference both in porcine alveolar macrophages and swine. Antivir Res 82:157–165
77. Li T, Liu B, Spalding MH, Weeks DP, Yang B (2012) High-efficiency TALEN-based gene editing produces disease-resistant rice. Nat Biotechnol 30:390–392
78. Li L, Li Q, Bao Y et al (2014) RNAi-based inhibition of porcine reproductive and respiratory syndrome virus replication in transgenic pigs. J Biotechnol 171:17–24
79. Li P, Estrada JL, Burlak C et al (2015) Efficient generation of genetically distinct pigs in a single pregnancy using multiplexed single-guide RNA and carbohydrate selection. Xenotransplantation 22:20–31
80. Lillico SG, Proudfoot C, Carlson DF et al (2013) Live pigs produced from genome edited zygotes. Sci Rep 3:2847
81. Lisauskas SF, Cunha NB, Vianna GR et al (2008) Expression of functional recombinant human factor IX in milk of mice. Biotechnol Lett 30:2063–2069
82. Liu H, Chen Y, Niu Y et al (2014) TALEN-mediated gene mutagenesis in rhesus and cynomolgus monkeys. Cell Stem Cell 14:323–328
83. Lu D, Liu S, Shang S et al (2015) Production of transgenic-cloned pigs expressing large quantities of recombinant human lysozyme in milk. PLoS One 10:e0123551
84. Lutz AJ, Li P, Estrada JL et al (2013) Double knockout pigs deficient in N-glycolylneuraminic acid and galactose alpha-1,3-galactose reduce the humoral barrier to xenotransplantation. Xenotransplantation 20:27–35
85. Makarova KS, Haft DH, Barrangou R et al (2011) Evolution and classification of the CRISPR-Cas systems. Nat Rev Microbiol 9:467–477
86. Matsunari H, Nagashima H, Watanabe M et al (2013) Blastocyst complementation generates exogenic pancreas in vivo in apancreatic cloned pigs. Proc Natl Acad Sci USA 110:4557–4562
87. Mestas J, Hughes CC (2004) Of mice and not men: differences between mouse and human immunology. J Immunol 172:2731–2738
88. Moehle EA, Rock JM, Lee YL et al (2007) Targeted gene addition into a specified location in the human genome using designed zinc finger nucleases. Proc Natl Acad Sci USA 104:3055–3060
89. Mojica FJ, Diez-Villasenor C, Garcia-Martinez J, Soria E (2005) Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. J Mol Evol 60:174–182
90. Moore FE, Reyon D, Sander JD et al (2012) Improved somatic mutagenesis in zebrafish using transcription activator-like effector nucleases (TALENs). PLoS One 7:e37877
91. Morcol T, Akers RM, Johnson JL et al (1994) The porcine mammary gland as a bioreactor for complex proteins. Ann N Y Acad Sci 721:218–233
92. Moscou MJ, Bogdanove AJ (2009) A simple cipher governs DNA recognition by TAL effectors. Science 326:1501
93. Mussolino C, Cathomen T (2013) RNA guides genome engineering. Nat Biotechnol 31:208–209
94. Niu Y, Shen B, Cui Y et al (2014) Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos. Cell 156:836–843
95. Notarangelo LD (2010) Primary immunodeficiencies. J Allergy Clin Immunol 125:S182–S194
96. Nottle MB, Haskard KA, Verma PJ et al (2001) Effect of DNA concentration on transgenesis rates in mice and pigs. Transgenic Res 10:523–531
97. Paleyanda RK, Velander WH, Lee TK et al (1997) Transgenic pigs produce functional human factor VIII in milk. Nat Biotechnol 15:971–975
98. Petters RM, Alexander CA, Wells KD et al (1997) Genetically engineered large animal model for studying cone photoreceptor survival and degeneration in retinitis pigmentosa. Nat Biotechnol 15:965–970
99. Phelan JK, Bok D (2000) A brief review of retinitis pigmentosa and the identified retinitis pigmentosa genes. Mol Vis 6:116–124
100. Phelps CJ, Koike C, Vaught TD et al (2003) Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 299:411–414
101. Polejaeva IA, Chen SH, Vaught TD et al (2000) Cloned pigs produced by nuclear transfer from adult somatic cells. Nature 407:86–90
102. Potash AE, Wallen TJ, Karp PH et al (2013) Adenoviral gene transfer corrects the ion transport defect in the sinus epithelia of a porcine CF model. Mol Ther 21:947–953
103. Radecke S, Radecke F, Cathomen T, Schwarz K (2010) Zinc-finger nuclease-induced gene repair with oligodeoxynucleotides: wanted and unwanted target locus modifications. Mol Ther 18:743–753
104. Ramsoondar J, Vaught T, Ball S et al (2009) Production of transgenic pigs that express porcine endogenous retrovirus small interfering RNAs. Xenotransplantation 16:164–180
105. Renner S, Fehlings C, Herbach N et al (2010) Glucose intolerance and reduced proliferation of pancreatic beta-cells in transgenic pigs with impaired glucose-dependent insulinotropic polypeptide function. Diabetes 59:1228–1238
106. Renner S, Romisch-Margl W, Prehn C et al (2012) Changing metabolic signatures of amino acids and lipids during the prediabetic period in a pig model with impaired incretin function and reduced beta-cell mass. Diabetes 61:2166–2175
107. Renner S, Braun-Reichhart C, Blutke A et al (2013) Permanent neonatal diabetes in INS(C94Y) transgenic pigs. Diabetes 62:1505–1511
108. Reznikov LR, Dong Q, Chen JH et al (2013) CFTR-deficient pigs display peripheral nervous system defects at birth. Proc Natl Acad Sci USA 110:3083–3088
109. Riordan JR, Rommens JM, Kerem B et al (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245:1066–1073
110. Rogers CS, Hao Y, Rokhlina T et al (2008a) Production of CFTR-null and CFTR-DeltaF508 heterozygous pigs by adeno-associated virus-mediated gene targeting and somatic cell nuclear transfer. J Clin Invest 118:1571–1577
111. Rogers CS, Stoltz DA, Meyerholz DK et al (2008b) Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Science 321:1837–1841
112. Ross JW, Fernandez de Castro JP, Zhao J et al (2012) Generation of an inbred miniature pig model of retinitis pigmentosa. Invest Ophthalmol Vis Sci 53:501–507
113. Sander JD, Cade L, Khayter C, Reyon D, Peterson RT, Joung JK, Yeh JR (2011) Targeted gene disruption in somatic zebrafish cells using engineered TALENs. Nat Biotechnol 29:697–698
114. Schmidt C (2006) Belated approval of first recombinant protein from animal. Nat Biotechnol 24:877
115. Shimatsu Y, Horii W, Nunoya T, Iwata A, Fan J, Ozawa M (2016) Production of human apolipoprotein(a) transgenic NIBS miniature pigs by somatic cell nuclear transfer. Exp Anim 65:37–43
116. Simons JP, McClenaghan M, Clark AJ (1987) Alteration of the quality of milk by expression of sheep beta-lactoglobulin in transgenic mice. Nature 328:530–532
117. Slaymaker IM, Gao L, Zetsche B, Scott DA, Yan WX, Zhang F (2016) Rationally engineered Cas9 nucleases with improved specificity. Science 351:84–88
118. Smith J, Bibikova M, Whitby FG, Reddy AR, Chandrasegaran S, Carroll D (2000) Requirements for double-strand cleavage by chimeric restriction enzymes with zinc finger DNA-recognition domains. Nucleic Acids Res 28:3361–3369
119. Sommer JR, Estrada JL, Collins EB et al (2011) Production of ELOVL4 transgenic pigs: a large animal model for Stargardt-like macular degeneration. Br J Ophthalmol 95:1749–1754
120. Song KH, Kang YJ, Jin UH et al (2010) Cloning and functional characterization of pig CMP-N-acetylneuraminic acid hydroxylase for the synthesis of N-glycolylneuraminic acid as the xenoantigenic determinant in pig-human xenotransplantation. Biochem J 427:179–188
121. Song J, Zhong J, Guo X et al (2013) Generation of RAG 1- and 2-deficient rabbits by embryo microinjection of TALENs. Cell Res 23:1059–1062
122. Soutar AK, Naoumova RP (2007) Mechanisms of disease: genetic causes of familial hypercholesterolemia. Nat Clin Pract Cardiovasc Med 4:214–225
123. Stoltz DA, Rokhlina T, Ernst SE et al (2013) Intestinal CFTR expression alleviates meconium ileus in cystic fibrosis pigs. J Clin Invest 123:2685–2693
124. Sun N, Liang J, Abil Z, Zhao H (2012) Optimized TAL effector nucleases (TALENs) for use in treatment of sickle cell disease. Mol BioSyst 8:1255–1263
125. Sung YH, Baek IJ, Kim DH et al (2013) Knockout mice created by TALEN-mediated gene targeting. Nat Biotechnol 31:23–24
126. Suzuki S, Iwamoto M, Saito Y et al (2012) Il2rg gene-targeted severe combined immunodeficiency pigs. Cell Stem Cell 10:753–758
127. Swindle MM, Makin A, Herron AJ, Clubb FJ Jr, Frazier KS (2012) Swine as models in biomedical research and toxicology testing. Vet Pathol 49:344–356
128. Tesson L, Usal C, Menoret S et al (2011) Knockout rats generated by embryo microinjection of TALENs. Nat Biotechnol 29:695–696
129. Uddin B, Chen NP, Panic M, Schiebel E (2015) Genome editing through large insertion leads to the skipping of targeted exon. BMC Genom 16:1082
130. Umeyama K, Watanabe M, Saito H et al (2009) Dominant-negative mutant hepatocyte nuclear factor 1alpha induces diabetes in transgenic-cloned pigs. Transgenic Res 18:697–706
131. Van Cott KE, Butler SP, Russell CG et al (1999) Transgenic pigs as bioreactors: a comparison of gamma-carboxylation of glutamic acid in recombinant human protein C and factor IX by the mammary gland. Genet Anal 15:155–160
132. van der Oost J, Westra ER, Jackson RN, Wiedenheft B (2014) Unravelling the structural and mechanistic basis of CRISPR-Cas systems. Nat Rev Microbiol 12:479–492
133. Velander WH, Johnson JL, Page RL et al (1992a) High-level expression of a heterologous protein in the milk of transgenic swine using the cDNA encoding human protein C. Proc Natl Acad Sci USA 89:12003–12007
134. Velander WH, Page RL, Morcol T et al (1992b) Production of biologically active human protein C in the milk of transgenic mice. Ann N Y Acad Sci 665:391–403
135. Vilahur G, Padro T, Badimon L (2011) Atherosclerosis and thrombosis: insights from large animal models. J Biomed Biotechnol 2011:907575
136. Wakayama T, Perry AC, Zuccotti M, Johnson KR, Yanagimachi R (1998) Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei. Nature 394:369–374
137. Wall RJ, Pursel VG, Shamay A, McKnight RA, Pittius CW, Hennighausen L (1991) High-level synthesis of a heterologous milk protein in the mammary glands of transgenic swine. Proc Natl Acad Sci USA 88:1696–1700
138. Wang H, Yang H, Shivalila CS, Dawlaty MM, Cheng AW, Zhang F, Jaenisch R (2013) One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 153:910–918
139. Wang J, Exline CM, DeClercq JJ et al (2015a) Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors. Nat Biotechnol 33:1256–1263
140. Wang X, Zhou J, Cao C et al (2015b) Efficient CRISPR/Cas9-mediated biallelic gene disruption and site-specific knockin after rapid selection of highly active sgRNAs in pigs. Sci Rep 5:13348
141. Wang Y, Du Y, Shen B et al (2015c) Efficient generation of gene-modified pigs via injection of zygote with Cas9/sgRNA. Sci Rep 5:8256
142. Wang X, Cao C, Huang J et al (2016) One-step generation of triple gene-targeted pigs using CRISPR/Cas9 system. Sci Rep 6:20620
143. Watanabe M, Nakano K, Matsunari H et al (2013) Generation of interleukin-2 receptor gamma gene knockout pigs from somatic cells genetically modified by zinc finger nuclease-encoding mRNA. PLoS One 8:e76478
144. Wefers B, Meyer M, Ortiz O, Hrabe de Angelis M, Hansen J, Wurst W, Kuhn R (2013) Direct production of mouse disease models by embryo microinjection of TALENs and oligodeoxynucleotides. Proc Natl Acad Sci USA 110:3782–3787
145. Wei J, Ouyang H, Wang Y et al (2012) Characterization of a hypertriglyceridemic transgenic miniature pig model expressing human apolipoprotein CIII. FEBS J 279:91–99
146. Welsh MJ, Rogers CS, Stoltz DA, Meyerholz DK, Prather RS (2009) Development of a porcine model of cystic fibrosis. Trans Am Clin Climatol Assoc 120:149–162
147. Wheeler DG, Joseph ME, Mahamud SD et al (2012) Transgenic swine: expression of human CD39 protects against myocardial injury. J Mol Cell Cardiol 52:958–961
148. Whitworth KM, Lee K, Benne JA et al (2014) Use of the CRISPR/Cas9 system to produce genetically engineered pigs from in vitro-derived oocytes and embryos. Biol Reprod 91:78
149. Whyte JJ, Samuel M, Mahan E et al (2011a) Vascular endothelium-specific overexpression of human catalase in cloned pigs. Transgenic Res 20:989–1001
150. Whyte JJ, Zhao J, Wells KD et al (2011b) Gene targeting with zinc finger nucleases to produce cloned eGFP knockout pigs. Mol Reprod Dev 78:2
151. Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH (1997) Viable offspring derived from fetal and adult mammalian cells. Nature 385:810–813
152. Wu Z, Xu Z, Zou X et al (2013) Pig transgenesis by piggyBac transposition in combination with somatic cell nuclear transfer. Transgenic Res 22:1107–1118
153. Xin J, Yang H, Fan N et al (2013) Highly efficient generation of GGTA1 biallelic knockout inbred mini-pigs with TALENs. PLoS One 8:e84250
154. Yang D, Yang H, Li W et al (2011) Generation of PPARgamma mono-allelic knockout pigs via zinc-finger nucleases and nuclear transfer cloning. Cell Res 21:979–982
155. Yang L, Guell M, Niu D et al (2015) Genome-wide inactivation of porcine endogenous retroviruses (PERVs). Science 350:1101–1104
156. Yu S, Luo J, Song Z, Ding F, Dai Y, Li N (2011) Highly efficient modification of beta-lactoglobulin (BLG) gene via zinc-finger nucleases in cattle. Cell Res 21:1638–1640
157. Zaragoza C, Gomez-Guerrero C, Martin-Ventura JL et al (2011) Animal models of cardiovascular diseases. J Biomed Biotechnol 2011:497841
158. Zhang L, Jia R, Palange NJ et al (2015) Large genomic fragment deletions and insertions in mouse using CRISPR/Cas9. PLoS One 10:e0120396
159. Zhao J, Xu W, Ross JW et al (2015) Engineering protein processing of the mammary gland to produce abundant hemophilia B therapy in milk. Sci Rep 5:14176
160. Zhou X, Wang L, Du Y et al (2016) Efficient generation of gene-modified pigs harboring precise orthologous human mutation via CRISPR/Cas9-induced homology-directed repair in zygotes. Hum Mutat 37:110–118